Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 1308c

March 10, 2025 4:27 PM EDT

Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q4 EPS of ($13.08).

For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK